03:15 AM EDT, 09/09/2024 (MT Newswires) -- Michael Thomas Henderson, Director, Chief Executive Officer, on September 04, 2024, sold 40,000 shares in Apogee Therapeutics ( APGE ) for $1,904,841. Following the Form 4 filing with the SEC, Henderson has control over a total of 1,394,487 shares of the company, with 1,394,487 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1974640/000110465924097866/xslF345X05/tm2423502-1_4seq1.xml